Literaturnachweis - Detailanzeige
Autor/inn/en | Findling, Robert L.; Newcorn, Jeffrey H.; Malone, Richard P.; Waheed, Ayesha; Prince, Jefferson B.; Kratochvil, Christopher J. |
---|---|
Titel | Pharmacotherapy of Aggression in a 9-Year-Old with ADHD |
Quelle | In: Journal of the American Academy of Child & Adolescent Psychiatry, 46 (2007) 5, S.653 (6 Seiten)
PDF als Volltext |
Sprache | englisch |
Dokumenttyp | gedruckt; online; Zeitschriftenaufsatz |
ISSN | 0890-8567 |
Schlagwörter | Stellungnahme; Hyperactivity; Aggression; Attention Deficit Disorders; Drug Therapy; Children; Outcomes of Treatment; Symptoms (Individual Disorders); Behavior Modification; Injuries; Antisocial Behavior; Behavior Disorders; Case Studies |
Abstract | A 9-year-old boy presents for assessment and treatment of his reactive, impulsive aggressive behavior that has been present for approximately 2 years. Six months ago, his pediatrician started treatment with OROS methylphenidate (MPH), which was titrated to 36 mg/day. There was moderate improvement in symptoms of attention-deficit/hyperactivity disorder (ADHD) but minimal improvement in his aggression. His parents have been reasonably compliant with behavioral therapy for the past 2 months, but improvement in physical aggression has been limited. Last week he struck and injured a peer who cut in front of him in line. This was his third incident of aggressive behavior in school this year, leading to a 1-week suspension from school. On interview, he meets criteria for ADHD, combined subtype, and oppositional defiant disorder (ODD). There is no evidence of a mood, anxiety, substance use, or psychotic disorder. This article presents the opinions of five doctors on how they would handle this case vignette pharmacologically. (ERIC). |
Anmerkungen | Lippincott Williams & Wilkins. P.O. Box 1600, Hagerstown, MD 21741. Tel: 800-638-3030; Tel: 301-223-2300; Fax: 301-223-2400; Web site: http://www.lww.com/product/?0890-8567 |
Erfasst von | ERIC (Education Resources Information Center), Washington, DC |
Update | 2017/4/10 |